Literature DB >> 9706453

Prevalence and correlates of anxiety in Alzheimer's disease.

E Chemerinski1, G Petracca, F Manes, R Leiguarda, S E Starkstein.   

Abstract

We assessed a consecutive series of 398 patients with probable Alzheimer's disease (AD) for the presence of Generalized Anxiety Disorder (GAD) using a standardized neuropsychiatric evaluation. Five percent of patients showed GAD during the 4 weeks preceding the psychiatric evaluation. AD patients with GAD showed significantly higher scores of depression, irritability, overt aggression, mania, and pathological crying than AD patients without GAD. The most severe symptoms of anxiety were those of tension, fears, insomnia, and physical complaints.

Entities:  

Mesh:

Year:  1998        PMID: 9706453     DOI: 10.1002/(sici)1520-6394(1998)7:4<166::aid-da4>3.0.co;2-8

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  9 in total

1.  Characteristics of generalized anxiety disorder in patients with dementia.

Authors:  Jessica S Calleo; Mark E Kunik; Dana Reid; Cynthia Kraus-Schuman; Amber Paukert; Tziona Regev; Nancy Wilson; Nancy J Petersen; A Lynn Snow; Melinda Stanley
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-11-07       Impact factor: 2.035

2.  Concordance of self- and proxy-rated worry and anxiety symptoms in older adults with dementia.

Authors:  Andrea Bradford; Gretchen A Brenes; Roberta A Robinson; Nancy Wilson; A Lynn Snow; Mark E Kunik; Jessica Calleo; Nancy J Petersen; Melinda A Stanley; Amber B Amspoker
Journal:  J Anxiety Disord       Date:  2012-11-23

3.  Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior.

Authors:  Samantha J Hindle; Roeben N Munji; Elena Dolghih; Garrett Gaskins; Souvinh Orng; Hiroshi Ishimoto; Allison Soung; Michael DeSalvo; Toshihiro Kitamoto; Michael J Keiser; Matthew P Jacobson; Richard Daneman; Roland J Bainton
Journal:  Cell Rep       Date:  2017-10-31       Impact factor: 9.423

Review 4.  Late-life anxiety disorders: a review.

Authors:  Josien Schuurmans; Anton van Balkom
Journal:  Curr Psychiatry Rep       Date:  2011-08       Impact factor: 5.285

Review 5.  Towards defining restlessness in individuals with dementia.

Authors:  Natalie G Regier; Laura N Gitlin
Journal:  Aging Ment Health       Date:  2016-01-08       Impact factor: 3.658

6.  Dihydromyricetin ameliorates behavioral deficits and reverses neuropathology of transgenic mouse models of Alzheimer's disease.

Authors:  Jing Liang; Héctor E López-Valdés; Hilda Martínez-Coria; A Kerstin Lindemeyer; Yi Shen; Xuesi M Shao; Richard W Olsen
Journal:  Neurochem Res       Date:  2014-04-13       Impact factor: 3.996

Review 7.  Anxiety in dementia: a critical review.

Authors:  Paul J Seignourel; Mark E Kunik; Lynn Snow; Nancy Wilson; Melinda Stanley
Journal:  Clin Psychol Rev       Date:  2008-03-07

8.  Behavioral and psychological signs and symptoms of dementia: a practicing psychiatrist's viewpoint.

Authors:  J E Mintzer; D F Mirski; K S Hoernig
Journal:  Dialogues Clin Neurosci       Date:  2000-06       Impact factor: 5.986

Review 9.  Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline.

Authors:  Rossana Botto; Nicoletta Callai; Aurora Cermelli; Lorenzo Causarano; Innocenzo Rainero
Journal:  Neurol Sci       Date:  2022-04-23       Impact factor: 3.830

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.